Intellia Therapeutics
Revolutionize the course of medicine with CRISPR genome editing
Healthcare & MedicalFree
About Intellia Therapeutics
Intellia advances CRISPR-based in vivo gene editing with lipid nanoparticle delivery for liver and other tissues. Its systemic editing approach contrasts Kernal’s T-cell-specific selective mRNA programming, suiting genetic diseases more than scalable CAR-T.
What Intellia Therapeutics does
Intellia Therapeutics is a leading clinical-stage genome editing company developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. Its mission is to transform the lives of people with severe diseases by developing and commercializing potentially curative treatments. The company maintains an active pipeline with clinical trials focused on conditions such as Hereditary Angioedema and ATTR Amyloidosis, supported by patient stories and scientific publications.
Key features
- CRISPR-based genome editing
- Clinical-stage pipeline
- Focus on severe diseases
- Patient-centric development
- Scientific publications & presentations
Pricing
Free
Similar Products
Therapy for Black Girls
Culturally responsive mental health resources and therapist directory for Black women and girls.
Healthcare & MedicalFree
Manhattan Mental Health Counseling
NYC-based online therapy with licensed therapists accepting insurance for anxiety, trauma, and life transitions.
Healthcare & MedicalFree
T
Teen Counseling
Online therapy for teens and parents via text, phone, and video from licensed therapists.
Healthcare & MedicalFree